Abstract
AbstractAfter lifting the COVID-19 lockdown restrictions and opening businesses, screening is essential to prevent the spread of the virus. Group testing could be a promising candidate for screening to save time and resources. However, due to the high false-negative rate (FNR) of the RT-PCR diagnostic test, we should be cautious about using group testing because a group’s false-negative result identifies all the individuals in a group as uninfected. Repeating the test is the best solution to reduce the FNR, and repeats should be integrated with the group-testing method to increase the sensitivity of the test. The simplest way is to replicate the test twice for each group (the 2Rgt method). In this paper, we present a new method for group testing (the groupMix method), which integrates two repeats in the test. Then we introduce the 2-stage sequential version of both the groupMix and the 2Rgt methods. We compare these methods analytically regarding the sensitivity and the average number of tests. The tradeoff between the sensitivity and the average number of tests should be considered when choosing the best method for the screening strategy. We applied the groupMix method to screening 263 people and identified 2 infected individuals by performing 98 tests. This method achieved a 63% saving in the number of tests compared to individual testing. Our experimental results show that in COVID-19 screening, the viral load can be low, and the group size should not be more than 6; otherwise, the FNR increases significantly. A web interface of the groupMix method is publicly available for laboratories to implement this method.
Publisher
Cold Spring Harbor Laboratory
Reference13 articles.
1. The Detection of Defective Members of Large Populations
2. Sensitivity and specificity of pooled versus individual sera in a human immunodeficiency virus antibody prevalence study;J. Clin. Microbiol,1989
3. Do we know the diagnostic properties of the tests used in COVID-19? A rapid review of recently published literature
4. A. N. Cohen and B. Kessel , “False positives in reverse transcription pcr testing for SARS-CoV-2,” medRxiv, 2020. [Online]. Available: https://www.medrxiv.org/content/early/2020/05/20/2020.04.26.20080911
5. V. M. Corman , O. Landt , M. Kaiser , R. Molenkamp , A. Meijer , D. K. Chu , T. Bleicker , S. Brunink , J. Schneider , M. L. Schmidt , D. G. Mulders , B. L. Haagmans , B. van der Veer , S. van den Brink , L. Wijsman , G. Goderski , J. L. Romette , J. Ellis , M. Zambon , M. Peiris , H. Goossens , C. Reusken , M. P. Koopmans , and C. Drosten , “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR,” Euro Surveill., vol. 25, no. 3, 01 2020.